Skip to contentBYBEE CLINTON — IMPINJ INC insider: 195 transactions · InsiderLensBYBEE CLINTON
- 10% owner at Neumora Therapeutics, Inc. · on record since Sep 20, 2023
- 10% owner at BOLD ENERGY INC. · on record since Mar 27, 2024
- 10% owner at CELEBRATE EXPRESS, INC. · on record since Sep 3, 2008
- 10% owner at Trubion Pharmaceuticals, Inc · on record since Oct 25, 2006
- 10% owner at NeurogesX Inc · on record since May 9, 2007
- 10% owner at ALNYLAM PHARMACEUTICALS, INC. · on record since Jun 1, 2004
- 10% owner at Lyell Immunopharma, Inc. · on record since Jun 23, 2021
- 10% owner at ILLUMINA INC · on record since Dec 1, 2003
- 10% owner at KYTHERA BIOPHARMACEUTICALS INC · on record since Oct 16, 2012
- 10% owner at BLUE HOLDINGS, INC. · on record since Jun 26, 2013
- 10% owner at Receptos, Inc. · on record since May 14, 2013
- 10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Jul 31, 2013
- 10% owner at FATE THERAPEUTICS INC · on record since Sep 30, 2013
- Former 10% Holder at ILLUMINA INC · on record since Feb 5, 2004
- 10% owner at Achaogen Inc · on record since Mar 17, 2014
- 10% owner at SAGE FUND LP · on record since Jul 23, 2014
- 10% owner at PAULSON CAPITAL CORP · on record since Aug 4, 2014
- 10% owner at JUNO LIGHTING INC · on record since Dec 23, 2014
- 10% owner at XCYTE THERAPIES INC · on record since Mar 10, 2004
- 10% owner at Bellerophon Therapeutics, Inc. · on record since Feb 23, 2015
- 10% owner at Ruthigen, Inc. · on record since Jun 25, 2015
- 10% owner at ADESTO TECHNOLOGIES Corp · on record since Oct 28, 2015
- Director at XTERA COMMUNICATIONS, INC. · on record since Nov 18, 2015
- 10% owner at XTERA COMMUNICATIONS, INC. · on record since Nov 18, 2015
- 10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
- 10% owner at PHASERX, INC. · on record since May 25, 2016
- Director at IMPINJ INC · on record since Aug 30, 2016
- 10% owner at IMPINJ INC · on record since Aug 30, 2016
- 10% owner at Sienna Biopharmaceuticals, Inc. · on record since Jul 26, 2017
- 10% owner at Quanterix Corp · on record since Dec 13, 2017
- 10% owner at Denali Therapeutics Inc. · on record since Dec 12, 2017
- 10% owner at Q32 Bio Inc. · on record since Mar 27, 2018
- 10% owner at Scholar Rock Holding Corp · on record since May 31, 2018
- 10% owner at Unity Biotechnology, Inc. · on record since May 7, 2018
- Former 10% owner at Ruthigen, Inc. · on record since Apr 5, 2018
- 10% owner at Twist Bioscience Corp · on record since Oct 30, 2018
- 10% owner at Gossamer Bio, Inc. · on record since Feb 12, 2019
- 10% owner at Karuna Therapeutics, Inc. · on record since Jun 27, 2019
- 10% owner at CHARTWELL DIVIDEND & INCOME FUND INC · on record since Aug 12, 2019
- 10% owner at VIRCO MFG CORPORATION · on record since Oct 18, 2019
- 10% owner at Beam Therapeutics Inc. · on record since Feb 11, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at 908 Devices Inc. · on record since Dec 22, 2020
- 10% owner at Codiak BioSciences, Inc. · on record since Oct 20, 2020
- 10% owner at Sana Biotechnology, Inc. · on record since Feb 10, 2021
Insider trading activity of BYBEE CLINTON
- Transactions on record
- 195
- since Dec 1, 2003
- Open-market buys
- 12
- $30.1M
- Open-market sells
- 0
- Companies traded
- 22
- last filing Aug 22, 2022
Figures computed from official regulatory filings — methodology.
Companies where BYBEE CLINTON has traded
- VIRCO MFG CORPORATION17 tx · Aug 22, 2022
- Beam Therapeutics Inc.18 tx · Jun 29, 2021
- Karuna Therapeutics, Inc.14 tx · $3.2M · Jan 12, 2021
- 908 Devices Inc.7 tx · $6M · Dec 22, 2020
- Quanterix Corp8 tx · Nov 24, 2020
- IMPINJ INC34 tx · $1.4M · Oct 23, 2020
- Metacrine, Inc.10 tx · $3M · Sep 22, 2020
- CHARTWELL DIVIDEND & INCOME FUND INC1 tx · Aug 12, 2019
- Unity Biotechnology, Inc.10 tx · May 7, 2018
- Q32 Bio Inc.
Track record of BYBEE CLINTON
Statistical track record
Free- Open-market buys
- 17
- Last buy
- Dec 22, 2020
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BYBEE CLINTON
Co-insiders of BYBEE CLINTON
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
3 tx · Apr 4, 2018
ARCH Venture Fund IX Overage, L.P.Beam Therapeutics Inc. +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Aug 22, 2022 | Other | -217,781 | 0.00 USD | $0 | SEC |
| Aug 22, 2022 | Other | -282,219 | 0.00 USD | $0 | SEC |
| Aug 22, 2022 | Other | 2,952 | 0.00 USD | $0 | SEC |
| Aug 22, 2022 | Other | 1,475 | 0.00 USD | $0 | SEC |
| Aug 22, 2022 | Other | 13,076 | 0.00 USD | $0 | SEC |
| Dec 1, 2021 | Other | -217,781 | 0.00 USD | $0 | SEC |
| Dec 1, 2021 | Other | 13,057 | 0.00 USD | $0 | SEC |
| Dec 1, 2021 | Other | -282,219 | 0.00 USD | $0 | SEC |
| Dec 1, 2021 | Other | 4,428 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 2,555 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | -200,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 2,555 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | -200,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | -200,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 811 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 4,686 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | -200,000 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 811 | 0.00 USD | $0 | SEC |
| Jun 29, 2021 | Other | 4,686 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | 3,160 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | -282,219 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | 1,016 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | 1,014 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | -217,781 | 0.00 USD | $0 | SEC |
| Apr 1, 2021 | Other | -217,781 | 0.00 USD | $0 | SEC |